The relative expression of rat Col1a1 mRNA in the BLM + Nintedanib and BLM + HUMSCs groups decreased significantly compared to that in the BLM group on day 49 (Fig. 5e). The gene discussed is COL1A1; the disease is Bloom syndrome.